Jan Pander
Impact in
-
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
-
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 7
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 2
-
- Gene expression and cancer classification 1
- Cancer therapeutics and mechanisms 1
- Bioinformatics and Genomic Networks 1
- Co-authors
- Hans Gelderblom (9 shared papers)Henk‐Jan Guchelaar (9 shared papers)Tahar van der Straaten (5 shared papers)Cornelis J.A. Punt (3 shared papers)Sjoerd H. van der Burg (1 shared paper)Moniek Heusinkveld (1 shared paper)Ekaterina S. Jordanova (1 shared paper)Hans Morreau (1 shared paper)
- Journals
- Annals of Oncology (1 paper)PLoS ONE (1 paper)Clinical Cancer Research (1 paper)BMC Nephrology (1 paper)Preventive Medicine Reports (1 paper)
- Partner nations
- NetherlandsGermanyTaiwan
In The Last Decade
Jan Pander
12 papers receiving 287 citations
Peers
Comparison fields: 5 of 47
- Oncology 151
- Immunology 69
- Cancer Research 31
- Hepatology 12
- Pulmonary and Respiratory Medicine 40
Countries citing papers authored by Jan Pander
This map shows the geographic impact of Jan Pander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Pander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Pander more than expected).
Fields of papers citing papers by Jan Pander
This network shows the impact of papers produced by Jan Pander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Pander. The network helps show where Jan Pander may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Pander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 90 | |
| 2 | 2010 | 64 | |
| 3 | 2007 | 42 | |
| 4 | 2010 | 31 | |
| 5 | 2007 | 14 | |
| 6 | 2009 | 13 | |
| 7 | 2010 | 13 | |
| 8 | 2015 | 11 | |
| 9 | Pharmacogenetics of small-molecule tyrosine kinase inhibitors: Optimizing the magic bullet. | 2010 | 8 |
| 10 | 2025 | 3 | |
| 11 | 2023 | 2 | |
| 12 | 2024 | 1 | |
| 13 | 2011 | 0 |
About Jan Pander
Jan Pander is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Infectious Diseases and Nephrology, having authored 13 papers that have together received 292 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (2 papers), HER2/EGFR in Cancer Research (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Gene expression and cancer classification (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Cancer therapeutics and mechanisms (1 paper) and Bioinformatics and Genomic Networks (1 paper). The work is most often cited by research in Oncology (151 citations), Immunology (69 citations), Cancer Research (31 citations), Hepatology (12 citations) and Pulmonary and Respiratory Medicine (40 citations). Jan Pander has collaborated with scholars based in Netherlands, Germany and Taiwan. Frequent co-authors include Hans Gelderblom, Henk‐Jan Guchelaar, Tahar van der Straaten, Cornelis J.A. Punt, Sjoerd H. van der Burg, Moniek Heusinkveld, Ekaterina S. Jordanova, Hans Morreau, Thorbald van Hall and Renée Baak-Pablo. Their work appears in journals such as Annals of Oncology, PLoS ONE, Clinical Cancer Research, BMC Nephrology and Preventive Medicine Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.